What is Core Quantum Technologies?
Core Quantum Technologies operates at the intersection of advanced materials science and biomedical engineering. The company specializes in the development of micelle-encapsulated nanocrystals, specifically its signature MultiDots and MagDots, which provide unblinking, high-fidelity insights into nanoscale activity. By overcoming the inherent limitations of traditional quantum dots—such as signal fading and blinking—the company provides researchers with the tools necessary to capture sharper, more consistent data. This technological breakthrough is rooted in foundational research from Ohio State University, where co-founders Dr. Jessica Winter and Dr. Gang Ruan pioneered methods to aggregate nanocrystals within protective polymers, thereby enhancing both signal longevity and structural durability for laboratory applications.
How much funding has Core Quantum Technologies raised?
Core Quantum Technologies has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
Key Investors in Core Quantum Technologies
PPP
Public-Private Partnership
What's next for Core Quantum Technologies?
With this latest round of financing, Core Quantum Technologies is poised to deepen its market penetration within the life sciences and diagnostic sectors. The strategic focus will likely shift toward scaling manufacturing capabilities to meet the growing demand for high-precision biological probes. Furthermore, the company is expected to leverage its enhanced capital position to expand its research and development pipeline, potentially exploring new applications for its magnetic and fluorescent tracking technologies in clinical diagnostics. As the firm matures, the emphasis will remain on bridging the gap between academic innovation and industrial-grade reliability, ensuring that its nanocrystal solutions become a standard component in the global biotechnology toolkit.
See full Core Quantum Technologies company page
